IGM Biosciences, Inc. Skyrocketed

IGM Biosciences, Inc. (IGMS:NASDAQ) soared at $115.03, representing a gain of 57.7%. On Mon 07 Dec 20, IGMS:NASDAQ hit a New 2-Week High of $72.92. The stock got featured on our News Catalysts scanner on Mon 07 Dec 20 at 07:32 PM in the 'PUBLIC OFFERING' category. From Mon 23 Nov 20, the stock recorded 55.56% Up Days and 50.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About IGM Biosciences, Inc. (IGMS:NASDAQ)

IGM Biosciences Inc is a biotechnology company involved in the development of engineered IgM antibodies for the treatment of cancer patients. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.